Cargando…

Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection

Interferon regulatory factor 4 (IRF4) is expressed in immune cells and is a member of the interferon regulatory factor family. Recently, it has been found that IRF4 plays important roles in the acute kidney injury (AKI)-chronic kidney disease (CKD) transition, glomerular diseases and kidney allograf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jianling, Ke, Ben, Tu, Weiping, Fang, Xiangdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538460/ https://www.ncbi.nlm.nih.gov/pubmed/37755331 http://dx.doi.org/10.1080/0886022X.2023.2259228

Ejemplares similares

Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Meta-analysis of AKI to CKD transition in perioperative patients
por: M. Abdala, Pedro, et al.
Publicado: (2021)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease
por: Lee, Kyung, et al.
Publicado: (2022)

Regulatory T Cells in the Immunodiagnosis and Outcome of Kidney Allograft Rejection
por: Franzese, O., et al.
Publicado: (2013)

The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023)

Altered gut microbiome plays an important role in AKI to CKD transition in aged mice
por: Kim, Myung-Gyu, et al.
Publicado: (2023)

REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
por: Gong, Shuiqin, et al.
Publicado: (2023)

Dynamic signature of lymphangiogenesis during AKI and CKD
por: Zarjou, Abolfazl, et al.
Publicado: (2019)

Relevant biomarkers of kidney allograft rejection
por: Loga, Luminița, et al.
Publicado: (2022)

Association of nocturia of self-report with estimated glomerular filtration rate: a cross-sectional study from the NHANES 2005–2018
por: Song, Jianling, et al.
Publicado: (2023)

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI–CKD transition
por: Hu, Zhizhi, et al.
Publicado: (2023)

C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection
por: Goutaudier, Valentin, et al.
Publicado: (2019)

From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
por: Wang, Zhiwen, et al.
Publicado: (2022)

Effector and Regulatory T Cell Trafficking in Corneal Allograft Rejection
por: Amouzegar, Afsaneh, et al.
Publicado: (2017)

Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation
por: Yu, Xiaobo, et al.
Publicado: (2014)

Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
por: Boer, Karin, et al.
Publicado: (2016)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
por: Guan, Xu, et al.
Publicado: (2022)

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022)

Retraction: Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation
Publicado: (2019)

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
por: Kant, Sam, et al.
Publicado: (2020)

IL-18 deficiency ameliorates the progression from AKI to CKD
por: Luan, Junjun, et al.
Publicado: (2022)

The Role of Regulatory Myeloid Cell Therapy in Renal Allograft Rejection
por: Zhuang, Jingming, et al.
Publicado: (2021)

Tubular Elabela-APJ axis attenuates ischemia-reperfusion induced acute kidney injury and the following AKI-CKD transition by protecting renal microcirculation
por: Xiong, Mingrui, et al.
Publicado: (2023)

Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation
por: Nishida, Kento, et al.
Publicado: (2021)

Uncovering a novel role of focal adhesion and interferon-gamma in cellular rejection of kidney allografts at single cell resolution
por: Halawi, Ahmad, et al.
Publicado: (2023)

EGFR drives the progression of AKI to CKD through HIPK2 overexpression
por: Xu, Luyang, et al.
Publicado: (2019)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

The therapeutic challenge of late antibody‐mediated kidney allograft rejection
por: Böhmig, Georg A., et al.
Publicado: (2019)

Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection
por: Lim, Jeong-Hoon, et al.
Publicado: (2022)

The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD
por: Kim, Dong-Hyun, et al.
Publicado: (2021)

Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
por: Chen, Jia-Huang, et al.
Publicado: (2021)

Allorecognition by T Lymphocytes and Allograft Rejection
por: Marino, Jose, et al.
Publicado: (2016)

Therapies for Chronic Allograft Rejection
por: Kim, Min Young, et al.
Publicado: (2021)

Suppression of allograft rejection by regulatory B cells induced via TLR signaling
por: Lee, Kang Mi, et al.
Publicado: (2022)

Value of plasma neutrophil gelatinase-associated lipocalin (NGAL) in distinguishing between acute kidney injury (AKI) and chronic kidney disease (CKD)
por: Corbacıoglu, Seref Kerem, et al.
Publicado: (2017)

MG53: A potential therapeutic target for kidney disease
por: Ke, Ben, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2gs3as7ksrp3l3jjv8mq73qlgm